Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Ovarian Cancer,2008,NCI,5K08CA106597-03,,Chromatin structure and BRCA1 Checkpoint Function,"GREENBERG, ROGER",UNIVERSITY OF PENNSYLVANIA,PA,"$135,677"
Ovarian Cancer,2008,NCI,5R01CA119200-02,,Optical Imaging of Ovarian Carcinogenesis in a Rat Menopause Model,"BARTON, JENNIFER",UNIVERSITY OF ARIZONA,AZ,"$282,857"
Ovarian Cancer,2008,NCI,5R37CA034992-26,,CHEMISTRY AND BIOLOGY OF PLATINUM ANTICANCER DRUGS,"LIPPARD, STEPHEN",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$672,247"
Ovarian Cancer,2008,NCI,5R21CA125227-02,,Microvascular Perfusion Sonographic Imaging to Detect Early Stage Ovarian Cancer,"FISHMAN, DAVID",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$164,859"
Ovarian Cancer,2008,NIGMS,5R01GM073823-03,,Functions for Myosin VI in the kidney proximal tubule,"MOOSEKER, MARK",YALE UNIVERSITY,CT,"$324,848"
Ovarian Cancer,2008,NCI,5R21CA116525-02,,Design of targeted native tropism-ablated adenovirus,"DMITRIEV, IGOR",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$145,500"
Ovarian Cancer,2008,NCI,5R21CA115568-02,,Design of targeted cell vehicles to ovarian carcinoma,"PEREBOEVA, LARISA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$174,600"
Ovarian Cancer,2008,NCI,5R01CA120409-03,,Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells,"JUNE, CARL",UNIVERSITY OF PENNSYLVANIA,PA,"$266,186"
Ovarian Cancer,2008,NCI,5R01CA079756-08,,P53-Mediated G1/M Checkpoint Controls Altered by PPM1D,"MERCER, W",THOMAS JEFFERSON UNIVERSITY,PA,"$238,892"
Ovarian Cancer,2008,NCI,1R01CA131407-01,,Re-activating Memory T Cells in the Microenvironment of Human Tumors,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$370,088"
Ovarian Cancer,2008,NCI,5R01CA101826-05,,HOX genes in ovarian neoplasia,"NAORA, HONAMI",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$234,808"
Ovarian Cancer,2008,NCI,5R01CA109619-04,,Polyamine Catabolism in Platinum Drug Action,"PENDYALA, LAKSHMI",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$297,716"
Ovarian Cancer,2008,NCI,5R01CA049449-19,,Biochemical Markers in the nurses' Health Study Cohort,"HANKINSON, SUSAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$1,213,763"
Ovarian Cancer,2008,NCI,2P01CA070970-10A1,0006,Cancer Stem Cells in Acute Lymphoblastic Leukemia and Ovarian Carcinoma,"JONES, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$337,575"
Ovarian Cancer,2008,NCI,5R01CA111882-03,,Regulation of Adhesion and Proteolysis in Ovarian Cancer,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$264,562"
Ovarian Cancer,2008,NCI,5R01CA060651-16,,Mouse Models to Study Gonadal Tumor Development,"MATZUK, MARTIN",BAYLOR COLLEGE OF MEDICINE,TX,"$265,968"
Ovarian Cancer,2008,NINR,1R21NR010571-01,,The Feasibility of Earlier Detection of Ovarian Cancer Using Symptom Reports,"ANDERSEN, M",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$224,927"
Ovarian Cancer,2008,NCI,5R01CA111914-04,,Ovarian Cancer and Mismatch Repair Deficiency,"PAL, TUYA",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$414,533"
Ovarian Cancer,2008,NCI,5R01CA039742-24,,Epidemiology of Cancer in a Cohort of Older Women,"FOLSOM, AARON",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$522,496"
Ovarian Cancer,2008,NCI,5R01CA104378-05,,Therapeutic targeting of HSP90-dependent signaling,"KARNITZ, LARRY","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$258,036"
Ovarian Cancer,2008,NCI,5R01CA103920-05,,BRCA1 and the Inactive X Chromosome,"LIVINGSTON, DAVID",DANA-FARBER CANCER INSTITUTE,MA,"$329,983"
Ovarian Cancer,2008,NCI,5U10CA013612-35,,SOUTHWEST ONCOLOGY GROUP,"MILLER, THOMAS",UNIVERSITY OF ARIZONA,AZ,"$266,506"
Ovarian Cancer,2008,NCI,1R01CA132091-01,,Targeted Nanoparticle DNA Therapy for Ovarian Cancer,"SAWICKI, JANET",LANKENAU INSTITUTE FOR MEDICAL RESEARCH,PA,"$304,559"
Ovarian Cancer,2008,NCI,1R01CA122728-01A2,,Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE,"SANTIN, ALESSANDRO",YALE UNIVERSITY,CT,"$346,272"
Ovarian Cancer,2008,NCI,1R01CA123233-01A2,,Regulation of JNK-signaling molecules by the gep oncogenes,"DHANASEKARAN, DANNY",TEMPLE UNIVERSITY,PA,"$280,125"
Ovarian Cancer,2008,NIGMS,2R01GM052418-09,,Mass Spectrometry Studies on Radical Reactions of DNA,"KENTTAMAA, HILKKA",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$216,530"
Ovarian Cancer,2008,NCI,1R01CA127239-01A1,,pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics,"NATARAJAN, AMARNATH",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$270,000"
Ovarian Cancer,2008,NCI,5R01CA114343-02,,Haplotype-Based Genome Screen for Ovarian Cancer Loci,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$1,510,342"
Ovarian Cancer,2008,NCI,5R01CA109298-04,,Ovarian Cancer: Mechanisms of Neuroendocrine Regulation,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$271,595"
Ovarian Cancer,2008,NCI,1R01CA123219-01A2,,The Role of Aberrant Splicing of EVl1 in Ovarian Cancer Pathophysiology,"MILLS, GORDON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$327,989"
Ovarian Cancer,2008,NCI,5F31CA126474-02,,Role of Src in Stress-Mediated Progression of Ovarian Cancer,"ARMAIZ-PENA, GUILLERMO",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$38,115"
Ovarian Cancer,2008,NCI,5R01CA116674-03,,Epigenetic regulation of cancer/germ-line antigen gene expression,"KARPF, ADAM",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$275,878"
Ovarian Cancer,2008,NCI,1R44CA123785-01A2,,Fast-Track:Biomagnetic In-vivo Imaging of Ovarian Cancer,"FLYNN, EDWARD",SENIOR SCIENTIFIC,NM,"$208,371"
Ovarian Cancer,2008,NCI,2R01CA103937-04,,Molecular Diagnostics for Malignant Effusion,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$338,148"
Ovarian Cancer,2008,NCI,5R01CA124630-02,,PTTG Role in Ovarian Tumorigenesis and Matastasis,"KAKAR, SHAM",UNIVERSITY OF LOUISVILLE,KY,"$253,080"
Ovarian Cancer,2008,NCI,5R01CA106713-04,,Mechanism of SHeA2 Action in Ovarian Cancer,"BENBROOK, DORIS",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$272,533"
Ovarian Cancer,2008,NCI,5R01CA087660-09,,Chemical Approaches for Activity Based Proteomics,"CRAVATT, BENJAMIN",SCRIPPS RESEARCH INSTITUTE,CA,"$323,425"
Ovarian Cancer,2008,NCI,5R01CA112291-04,,"BRIT 1: Roles in Immortalization, Checkpoints and Cancer","LIN, SHIAW-YIH",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$252,809"
Ovarian Cancer,2008,NCI,5R01CA103924-05,,Molecular characterization of ovarian cancer in a mouse model,"ORSULIC, SANDRA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$305,173"
Ovarian Cancer,2008,NCI,7R01CA079716-11,,Ovarian Cancer: Epithelial Dedifferentiation,"XU, XIANGXI",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$326,412"
Ovarian Cancer,2008,NCI,5R01CA051578-16,,A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY,"KOPECEK, JINDRICH",UNIVERSITY OF UTAH,UT,"$236,153"
Ovarian Cancer,2008,NCI,5R01CA111786-04,,Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction,"RABINOWICH, HANNAH",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$268,039"
Ovarian Cancer,2008,NCI,5R01CA111334-04,,Vitamin D and Ovarian Cancer Prevention and Treatment,"BAI, WENLONG",UNIVERSITY OF SOUTH FLORIDA,FL,"$244,382"
Ovarian Cancer,2008,NCI,5R01CA123197-02,,Death Receptor-mediated Apoptosis and Therapy Strategies in Ovarian Cancer,"ZHOU, TONG",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$439,913"
Ovarian Cancer,2008,NCI,5R01CA107195-04,,Loss of Vitamin A Metabolism in Ovarian Oncogenesis,"HAMILTON, THOMAS",FOX CHASE CANCER CENTER,PA,"$284,831"
Ovarian Cancer,2008,NCI,5R01CA095023-06,,Inflammation and Ovarian Cancer,"NESS, ROBERTA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$473,730"
Ovarian Cancer,2008,NCI,5R01CA106298-05,,Imbalancing DNA BER to enhance Ovarian Tumor Sensitivity,"KELLEY, MARK",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$285,864"
Ovarian Cancer,2008,NCI,5R21CA128222-02,,Infectivity Enhanced Virotherapy For Ovarian Cancer,"ALVAREZ, RONALD",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$275,500"
Ovarian Cancer,2008,NCI,5R01CA112162-04,,The role of complement in ovarian cancer,"LAMBRIS, JOHN",UNIVERSITY OF PENNSYLVANIA,PA,"$296,817"
Ovarian Cancer,2008,NCI,5R01CA113783-04,,Development of tumor based antigen presenting cells,"RILEY, JAMES",UNIVERSITY OF PENNSYLVANIA,PA,"$262,249"
Ovarian Cancer,2008,NHGRI,5R01HG004064-02,,Do Physicians Understand Uncertain Variants and Other Genetic Test Results?,"PLON, SHARON",BAYLOR COLLEGE OF MEDICINE,TX,"$331,088"
Ovarian Cancer,2008,NCI,5R01CA086061-08,,Mechanistic Comparison of Cisplatin with Synthetic DNA Repair-Shielding Anticance,"ESSIGMANN, JOHN",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$282,619"
Ovarian Cancer,2008,NCI,5R01CA095071-07,,Epithelial Positioning Organization and Ovarian Cancer,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$323,942"
Ovarian Cancer,2008,NCI,5R01CA121119-02,,Autocrine Wnt signaling in human breast and ovarian cancer cells,"BAFICO, ANNA",MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NY,"$322,050"
Ovarian Cancer,2008,NCI,5R01CA107506-04,,Novel human gene-IG20-potential role in cancer therapy,"PRABHAKAR, BELLUR",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$261,235"
Ovarian Cancer,2008,NCI,5R01CA112570-05,,Progesterone-mediated protection against ovarian cancer,"HO, SHUK-MEI",UNIVERSITY OF CINCINNATI,OH,"$258,707"
Ovarian Cancer,2008,NCI,5R01CA120197-03,,KALLIKREINS AS DIAGNOSTIC MARKERS OF OVARIAN CARCINOMA,"DIAMANDIS, ELEFTHERIOS",MT SINAI HOSP-SAMUEL LUNENFELD RES INST,CANADA,"$216,880"
Ovarian Cancer,2008,NCI,5R01CA115483-04,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$301,109"
Ovarian Cancer,2008,NCI,5K05CA096558-05,,Psychological and Behavioral Impact of Cancer Screening,"ANDRYKOWSKI, MICHAEL",UNIVERSITY OF KENTUCKY,KY,"$128,411"
Ovarian Cancer,2008,NCI,5R01CA112354-04,,Modeling ovarian carcinoma by defined genetic alterations,"NIKITIN, ALEXANDER",CORNELL UNIVERSITY ITHACA,NY,"$266,292"
Ovarian Cancer,2008,NCI,5R01CA112523-03,,Steroid Hormone Genes and Ovarian Cancer Risk,"ROSSING, MARY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$782,880"
Ovarian Cancer,2008,NCI,5R21CA127837-02,,Web-based Family History Screening for Hereditary Breast Cancer Risk,"ACHESON, LOUISE",CASE WESTERN RESERVE UNIVERSITY,OH,"$154,500"
Ovarian Cancer,2008,NCI,5R01CA120429-02,,Regulation of MDR1 Expression and Drug Resistance by CD44,"RODRIGUEZ-RODRIGUEZ, LORNA",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$296,400"
Ovarian Cancer,2008,NCI,5R01CA099985-03,,Human Tregs in Ovarian Cancer,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$209,581"
Ovarian Cancer,2008,NCI,1K99CA133190-01,,Epidermal growth factor regulation of miR-125a promotes invasive ovarian cancer,"COWDEN DAHL, KAREN",UNIVERSITY OF NEW MEXICO,NM,"$120,150"
Ovarian Cancer,2008,NCI,5R01CA124515-02,,Vascular Leukocytes influence the tumor microenvironment,"CONEJO-GARCIA, JOSE",DARTMOUTH COLLEGE,NH,"$303,810"
Ovarian Cancer,2008,NCI,5R01CA125636-02,,The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer,"TANIGUCHI, TOSHIYASU",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$308,883"
Ovarian Cancer,2008,NCI,5R01CA123170-03,,MUC-1 related cancer immunity: determinants and predictive significance,"CRAMER, DANIEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$278,781"
Ovarian Cancer,2008,NCI,5R01CA108990-04,,Multianalyte Assay For Early Diagnosis Of Ovarian Cancer,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$517,492"
Ovarian Cancer,2008,NCI,5R01CA116984-02,,G Proteins and Their Receptors in Tumor Cell Metastasis,"DHANASEKARAN, DANNY",TEMPLE UNIVERSITY,PA,"$302,815"
Ovarian Cancer,2008,NCI,5R01CA083821-09,,Replicative adenoviruses with enhanced infectivity,"CURIEL, DAVID",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$247,476"
Ovarian Cancer,2008,NCI,5R01CA047988-18,,Women's Health Study: Continued Follow-up,"BURING, JULIE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$1,680,173"
Ovarian Cancer,2008,NCI,5R01CA115780-04,,Diagnosis of Ovarian Cancer by Confocal Microendoscopy,"GMITRO, ARTHUR",UNIVERSITY OF ARIZONA,AZ,"$279,194"
Ovarian Cancer,2008,NCI,5R03CA126775-02,,Symptom Measurement and Interrelationships During Chemotherapy for Ovarian Cancer,"JIM, HEATHER",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$83,000"
Ovarian Cancer,2008,NCI,5R01CA017393-33,,Mullerian Inhibiting Substance,"DONAHOE, PATRICIA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$324,032"
Ovarian Cancer,2008,NCI,5R01CA110793-05,,Tumor metastasis: Biobehavioral mechanisms,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$329,472"
Ovarian Cancer,2008,NCI,1R01CA123249-01A2,,Regulation of Serine Protease HtrA1 and Chemoresponse,"SHRIDHAR, VIJAYALAKSHMI","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$305,050"
Ovarian Cancer,2008,NCI,5R01CA121187-02,,Monitoring of advanced virotherapy for ovarian cancer,"CURIEL, DAVID",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$275,500"
Ovarian Cancer,2008,NCI,5R01CA106878-04,,Biomarkers with Biological Function in Ovarian Carcinoma,"SKUBITZ, AMY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$283,150"
Ovarian Cancer,2008,NCI,5R01CA092520-08,,Tumor Host Range Mutants of Polyoma and Their Targets,"BENJAMIN, THOMAS",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$617,981"
Ovarian Cancer,2008,NCI,1R01CA129080-01A1,,The Roles of HBXAP Gene in Ovarian Cancer,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$340,300"
Ovarian Cancer,2008,NCI,5F32CA125959-02,,Analysis of BRCA1/non-coding RNA interactions,"LU, SHIHUA",DANA-FARBER CANCER INSTITUTE,MA,"$51,278"
Ovarian Cancer,2008,NCI,5R01CA114037-02,,Taxane Resistance in Breast and Ovarian Cancer Cells,"SIKIC, BRANIMIR",STANFORD UNIVERSITY,CA,"$297,730"
Ovarian Cancer,2008,NCI,5R01CA118578-04,,The Mechanism of BRCA1 in Tumor Suppression,"HU, YANFEN",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$201,308"
Ovarian Cancer,2008,NCI,1R03CA133915-01,,Dietary Intervention in the Gallus Domesticus Model of Ovarian Cancer,"HALES, DALE",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$78,500"
Ovarian Cancer,2008,NCI,5K08CA106868-05,,Role of Phapl in apoptosome regulation in ovarian cancer,"LIU, J",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$138,510"
Ovarian Cancer,2008,NCI,5R01CA118158-03,,The role of BRCA1 in nonhomologous repair of chromosomal double-strand breaks,"XIA, FEN",VANDERBILT UNIVERSITY,TN,"$238,105"
Ovarian Cancer,2008,NCI,5R01CA123088-02,,Novel immunosupressive macrophages in human ovarian tumor,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$288,800"
Ovarian Cancer,2008,NCI,2R01CA085289-05A1,,DNA Methylation and Ovarian Cancer,"NEPHEW, KENNETH",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$264,396"
Ovarian Cancer,2008,NCI,5R01CA122581-03,,Tumor-Associated Antigens in Early Stage Serous Carcinoma,"RODEN, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$304,849"
Ovarian Cancer,2008,NCI,5K25CA120350-02,,A near-infrared contrast agent for targeted imaging of cancer,"ROMANOWSKI, MAREK",UNIVERSITY OF ARIZONA,AZ,"$134,083"
Ovarian Cancer,2008,NCI,5R01CA113891-03,,BARD1 phosphorylation in breast and ovarian cancer,"BAER, RICHARD",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$218,696"
Ovarian Cancer,2008,NCI,5R01CA118213-03,,Pharmacokinetic strategies to optimize IP chemotherapy,"BALTHASAR, JOSEPH",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$255,609"
Ovarian Cancer,2008,NCI,5R01CA119078-03,,CELL NON-AUTONOMOUS MODE OF TUMOR SUPPRESSION BY BRCA1,"DUBEAU, LOUIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$224,748"
Ovarian Cancer,2008,NCI,5R01CA094172-07,,Molecular Pathogenesis of Ovarian Endometrioid Adenocarcinomas,"CHO, KATHLEEN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$261,178"
Ovarian Cancer,2008,NCI,5R01CA109545-03,,Receptor Cross-Talk in Early Metastatic Dissemination,"STACK, MARY",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$243,979"
Ovarian Cancer,2008,NCI,5R01CA075334-11,,MRI studies of angiogenesis in ovarian cancer,"NEEMAN, MICHAL",WEIZMANN INSTITUTE OF SCIENCE,ISRAEL,"$102,771"
Ovarian Cancer,2008,NCI,5R01CA116779-03,,Vascular Leukocytes Induce regulatory T cells (Treg) in Tumors,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$271,456"
Ovarian Cancer,2008,NCI,5R01CA119388-04,,Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer Nanoparticle Conjugate,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$475,527"
Ovarian Cancer,2008,NCI,2R44CA103177-02A1,,Photodynamic Therapy of Disseminated Peritoneal Tumor Using New Photosensitizers,"WHARTON, J","LYNNTECH, INC.",TX,"$608,725"
Ovarian Cancer,2008,NCI,5R01CA106414-04,,Population-Based Analysis of Ovarian Cancer Biomarkers,"SUTPHEN, REBECCA",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$576,087"
Ovarian Cancer,2008,NCI,1R41CA126011-01A2,,PARP Inhibitor Targeted Therapy for Breast Cancer,"HOLT, JEFFREY","TISSUE GENETICS, INC.",CO,"$149,043"
Ovarian Cancer,2008,NCI,5U01CA111273-04,,Affinity-based Seurm Proteomics: Breast/Ovarian Cancer,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$658,549"
Ovarian Cancer,2008,NIGMS,1F32GM084587-01,,Mechanism of homology search in homologous recombination by Rad51 and Rad54.,"MOSES, DANA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$44,846"
Ovarian Cancer,2008,NCI,5R01CA118678-02,,Apoptotic regulators in ovarian cancer,"MOR, GIL",YALE UNIVERSITY,CT,"$314,450"
Ovarian Cancer,2008,NCI,5K25CA128666-02,,Comparative Proteomics Applied to the Avian Model of Ovarian Cancer,"HAWKRIDGE, ADAM",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$143,370"
Ovarian Cancer,2008,NCI,5R01CA122443-02,,Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology,"GOODE, ELLEN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$548,865"
Ovarian Cancer,2008,NIGMS,5F31GM078742-02,,Role of estrogen and its receptors in ovarian cancer of the hen,"TREVINO, LINDSEY",CORNELL UNIVERSITY ITHACA,NY,"$37,452"
Ovarian Cancer,2008,NCI,5R03CA123621-02,,c-Met Mediated Ovarian Cancer Cell Motility,"LO, CHUN-MIN",UNIVERSITY OF SOUTH FLORIDA,FL,"$72,500"
Ovarian Cancer,2008,NCI,5R01CA120061-04,,Hormone levels during pregnancy and maternal ovarian cancer,"LUKANOVA, ANNEKATRIN",GERMAN CANCER RESEARCH CENTER,GERM,"$386,251"
Ovarian Cancer,2008,NCI,5R03CA125766-02,,Methods for Statistical Analysis of Cancer Genetic Network Studies,"FINKELSTEIN, DIANNE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$87,500"
Ovarian Cancer,2008,NCI,7K01CA115593-04,,The Role of X-linked Gene Expression in Mammary Tumorigenesis,"HUYNH, KHANH",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$111,660"
Ovarian Cancer,2008,NCI,5K24CA087933-08,,Clinical Investigator Development in Solid Tumor Oncology,"SPRIGGS, DAVID",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$153,090"
Ovarian Cancer,2008,NCI,5R01CA105207-04,,Plasmacytoid dendritic cell behavior in ovarian cancer,"CURIEL, TYLER",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$273,408"
Ovarian Cancer,2008,NCI,5R01CA118846-02,,Regulation of gene silencing by exogenous sphingosine,"SCHMELZ, EVA",VIRGINIA POLYTECHNIC INST AND ST UNIV,VA,"$271,035"
Ovarian Cancer,2008,NCI,5F31CA123637-03,,Ovarian Cancer Biomarker Discovery using scFv Arrays,"RAMIREZ, ARTURO",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$33,009"
Ovarian Cancer,2008,NCI,5K07CA108987-03,,Clinical Relevance of Mismatch Repair in Ovarian Cancer,"PAL, TUYA",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$132,823"
Ovarian Cancer,2008,NCI,5R01CA086984-09,,Regulation of Ovarian Carcinoma Proteinases,"STACK, MARY",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$223,262"
Ovarian Cancer,2008,NCI,5K22CA121991-02,,Growth Inhibition Induced by Mifepristone in Ovarian Cancer,"TELLERIA, CARLOS",UNIVERSITY OF SOUTH DAKOTA,SD,"$138,745"
Ovarian Cancer,2008,NCI,5R01CA083855-09,,Prophytactic surgery in carriers of BRCA 1/2 mutations,"REBBECK, TIMOTHY",UNIVERSITY OF PENNSYLVANIA,PA,"$714,168"
Ovarian Cancer,2008,NHLBI,5R01HL090559-02,,Bayesian Modeling and Optimal Design for Studies of Gene-Environment Association,"IVERSEN, EDWIN",DUKE UNIVERSITY,NC,"$308,524"
Ovarian Cancer,2008,NCI,5K25CA111636-05,,Clinico-Genomics for Improved Ovarian Cancer Treatment,"CLARKE, JENNIFER",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$133,950"
Ovarian Cancer,2008,NCI,5R21CA124688-02,,p53 signatures and pelvic serous carcinoma,"CRUM, CHRISTOPHER",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$143,004"
Ovarian Cancer,2008,RMAP,5R01CA132630-02,,Chemical Probes for Metabolic Pathway Discovery in Human Disease,"CRAVATT, BENJAMIN",SCRIPPS RESEARCH INSTITUTE,CA,"$602,495"
Ovarian Cancer,2008,NCI,5R03CA132155-02,,Cancer Risks in Multi-ethnic Carriers of Unclassified BRCA1 Variants,"WHITTEMORE, ALICE",STANFORD UNIVERSITY,CA,"$79,000"
Ovarian Cancer,2008,NCI,5R01CA127562-02,,Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer,"UENO, NAOTO",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$292,600"
Ovarian Cancer,2008,NCI,5F32CA123651-03,,Liposomal Delivery of High LET Emitters to Cell Nuclei,"HAR-EL, YAH-EL",JOHNS HOPKINS UNIVERSITY,MD,"$50,428"
Ovarian Cancer,2008,NCI,5R01CA092889-07,,Role of TGFbeta in Microtubule Dynamics,"MULDER, KATHLEEN",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$259,572"
Ovarian Cancer,2008,NICHD,5K12HD055881-02,,VCU Building Interdisciplinary Research Careers in Women's Health,"STRAUSS, JEROME",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$50,000"
Ovarian Cancer,2008,OD,5K12HD055881-02,,VCU Building Interdisciplinary Research Careers in Women's Health,"STRAUSS, JEROME",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$446,801"
Ovarian Cancer,2008,NCI,1R01CA134487-01,,Mesothelin as biomarker and therapeutic target,"HELLSTROM, INGEGERD",UNIVERSITY OF WASHINGTON,WA,"$270,000"
Ovarian Cancer,2008,NCCAM,5R21AT004085-02,,Therapeutic Efficacy of Flax Seed in the Prevention of Ovarian Cancer,"HALES, DALE",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$191,568"
Ovarian Cancer,2008,OD,1R21CA134960-01,,Novel Ovarian Cancer Detection Agents from Phage Display,"DEUTSCHER, SUSAN",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$184,400"
Ovarian Cancer,2008,NIA,1R03AG032602-01,,Prophylactic oophorectomy: practice patterns & outcomes,"CHAN, JOHN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$77,152"
Ovarian Cancer,2008,NCI,1R01CA135312-01,,Dendritic nanomedicine for cancer imaging and treatment,"TUNG, CHING-HSUAN",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$294,650"
Ovarian Cancer,2008,NCI,1R01CA130911-01A1,,Chimeric NKG2D receptors in ovarian cancer immunotherapy,"SENTMAN, CHARLES",DARTMOUTH COLLEGE,NH,"$331,793"
Ovarian Cancer,2008,NCI,1R01CA127913-01A2,,MyD88-bearing tumors in immune-regulation and chemo-resistance,"MOR, GIL",YALE UNIVERSITY,CT,"$343,413"
Ovarian Cancer,2008,NCI,1R21CA133877-01A1,,A Low-Dose Decitabine Strategy for Restoring Ovarian Cancer Sensitivity,"MATEI, DANIELA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$341,397"
Ovarian Cancer,2008,NCI,1R21CA132016-01A1,,Evaluation of hGBP-1 as a marker for paclitaxel resistance in ovarian cancer,"VESTAL, DEBORAH",UNIVERSITY OF TOLEDO,OH,"$194,400"
Ovarian Cancer,2008,NCI,1K07CA131094-01A1,,Epigentics and Female Reproductive Cancers,"PERRIN, MARY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$139,320"
Ovarian Cancer,2008,NCI,1R21CA116585-01A1,,Inflammatory Markers in Circulation and Ovarian Cancer Risk,"ARSLAN, ALAN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$190,688"
Ovarian Cancer,2008,NHGRI,1R03HG004528-01A1,,Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis For Inherited,"RUBIN, LISA",NEW SCHOOL UNIVERSITY,NY,"$75,000"
Ovarian Cancer,2008,NCI,1R01CA131183-01A2,,"RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression","LIU, JINSONG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$255,640"
Ovarian Cancer,2008,NCI,1R41CA128145-01A2,,OVARIAN CANCER PROTEOME VIA TISSUE MICRODISSECTION AND GEMINI TECHNOLOGIES,"SAXENA, SATYA","CALIBRANT BIOSYSTEMS, INC.",MD,"$253,782"
Ovarian Cancer,2008,NCI,1R03CA132573-01A1,,Inflammatory Processes and Depression in a Syngeneic Model of Ovarian Cancer,"LAMKIN, DONALD",UNIVERSITY OF IOWA,IA,"$75,000"
Ovarian Cancer,2008,NCI,1R03CA136019-01,,Prolactin as a risk biomarker of ovarian cancer,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$75,750"
Ovarian Cancer,2008,NCI,1F32CA136152-01,,Targeted Photoactivated Nanoparticles for the Treatment of Ovarian Cancer,"NEUMAN, DANIEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$46,826"
Ovarian Cancer,2008,NINR,1R01NR010735-01A1,,Web-Based Ovarian Cancer Symptom Control: Nurse-Guided vs. Self-Directed,"DONOVAN, HEIDI",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$579,255"
Ovarian Cancer,2008,NCI,2R01CA095319-06A2,,Novel Fas/CD95 Signaling Mechanisms,"PETER, MARCUS",UNIVERSITY OF CHICAGO,IL,"$275,709"
Ovarian Cancer,2008,NCCAM,3U19AT002022-03S1,,NESA Acupuncture Research Collaborative,"WAYNE, PETER",NEW ENGLAND SCHOOL OF ACUPUNCTURE,MA,"$678,327"
Ovarian Cancer,2008,NCI,5U19CA113341-04,0002,OVARIAN CANCER MESOTHELIN ANIMAL MODEL/DNA VACCINES,"WU, T.-C.",JOHNS HOPKINS UNIVERSITY,MD,"$234,484"
Ovarian Cancer,2008,NCI,5U19CA113341-04,0003,EVALUATE LAG3 AND OTHER IMMUNE MODULATORS,"PARDOLL, DREW",JOHNS HOPKINS UNIVERSITY,MD,"$232,011"
Ovarian Cancer,2008,NCI,5U19CA113341-04,0004,EVALUATE B7H1/H4 IN MOUSE MODELS AND IN HUMAN PRE-CLINICAL STUDIES,"CHEN, LIEPING",JOHNS HOPKINS UNIVERSITY,MD,"$234,896"
Ovarian Cancer,2008,NHGRI,1R01HG005055-01,,INTERNET INTERVENTION FOR BRCA1/BRCA2 UNINFORMATIVES,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$751,312"
Ovarian Cancer,2008,NCI,5P01CA077839-10,0008,COX-1 as a Target for Ovarian Cancer Prevention and Treatment,"DEY, SUDHANSU",VANDERBILT UNIVERSITY,TN,"$184,787"
Ovarian Cancer,2008,NCI,5P30CA015083-34,9020,CORE-- Protocol-Specific Research Support,"ADJEI, ALEX","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$236,631"
Ovarian Cancer,2008,NCI,2U54CA096297-06A1,0008,"Synthesis and Pre-Clinical Evaluation of Targeted, Iron-Based MRI Contrast Agents","RAPTIS, RAPHAEL",UNIVERSITY OF PUERTO RICO,PR,"$88,939"
Ovarian Cancer,2008,NCI,3R01CA115483-04S1,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$59,963"
Ovarian Cancer,2008,NCI,5P01CA087969-09,0007,"HORMONES, DIET AND RISK OF OVARIAN CANCER","HANKINSON, SUSAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$234,582"
Ovarian Cancer,2008,NCI,5P01CA087969-09,0008,STATISTICAL INNOVATIONS IN RISK MODELING,"ROSNER, BERNARD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$152,114"
Ovarian Cancer,2008,NCI,3R01CA086984-09S1,,Regulation of Ovarian Carcinoma Proteinases,"STACK, MARY",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$48,237"
Ovarian Cancer,2008,NCI,5P01CA052477-16,0006,The Molecular Genetics of MUC16,"BOYD, JEFF",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$421,486"
Ovarian Cancer,2008,NCI,5P01CA052477-16,0007,Development of Antibody and T-Cell Inducing Vaccines,"LIVINGSTON, PHILIP",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$642,726"
Ovarian Cancer,2008,NCI,5P01CA052477-16,0008,Cellular Immunity Targeting Epithelial Ovarian Cancer,"O'REILLY, RICHARD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$352,723"
Ovarian Cancer,2008,NCI,5P01CA052477-16,0009,Novel Strategy for the Re-Induction & Consolidation of Remission in Ovary Cancer,"SPRIGGS, DAVID",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$231,061"
Ovarian Cancer,2008,NCI,5P01CA052477-16,9002,Core--Biostatistics,"THALER, HOWARD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$223,981"
Ovarian Cancer,2008,NCI,5P01CA052477-16,9003,Core--Pathology,"SOSLOW, ROBERT",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$165,319"
Ovarian Cancer,2008,NCI,5P50CA083636-10,0001,Molecular Targets for Prognosis and Therapy,"HOOD, LEROY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$567,737"
Ovarian Cancer,2008,NCI,5P50CA083636-10,0004,Biomarkers for Ovarian Cancer Diagnosis and Screening,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$143,018"
Ovarian Cancer,2008,NCI,5P50CA083636-10,0006,Adoptive T Cell Therapy of Ovarian Cancer,"YEE, CASSIAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$286,393"
Ovarian Cancer,2008,NCI,5P50CA083636-10,9001,Core--Leadership,"URBAN, NICOLE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$161,169"
Ovarian Cancer,2008,NCI,5P50CA083636-10,9002,Core--Clinical,"DRESCHER, CHARLES",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$251,362"
Ovarian Cancer,2008,NCI,5P50CA083636-10,9003,Core--Specimen,"KIVIAT, NANCY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$531,317"
Ovarian Cancer,2008,NCI,N02CN63300-3-0-4,,Computer Support for Ovarian Cancer Screening in PLCO Cancer Screening Trials,NO PI IDENTIFIED,"INFORMATION MANAGEMENT SERVICES, INC.",MD,"$283,111"
Ovarian Cancer,2008,NCI,5P30CA006927-46,9036,CORE--TRANSGENIC MOUSE,"YOUNG, ROBERT",FOX CHASE CANCER CENTER,PA,"$153,052"
Ovarian Cancer,2008,NIGMS,3R01GM052418-09S1,,Mass Spectrometry Studies on Radical Reactions of DNA,"KENTTAMAA, HILKKA",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$24,527"
Ovarian Cancer,2008,NCI,N1CN25524A-73-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial",NO PI IDENTIFIED,UNIVERSITY OF UTAH,UT,"$575,720"
Ovarian Cancer,2008,NCI,N1CN25522A-91-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,GEORGETOWN UNIVERSITY,DC,"$690,195"
Ovarian Cancer,2008,NCI,N1CN25518A-88-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial",NO PI IDENTIFIED,MARSHFIELD CLINIC RESEARCH FOUNDATION,WI,"$677,003"
Ovarian Cancer,2008,NCI,N1CN25516A-90-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,,,"$441,068"
Ovarian Cancer,2008,NCI,N1CN25515A-83-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial",NO PI IDENTIFIED,PACIFIC HEALTH RESEARCH INSTITUTE,HI,"$1,087,832"
Ovarian Cancer,2008,NCI,N1CN25514A-77-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,,,"$642,088"
Ovarian Cancer,2008,NCI,N1CN25513A-89-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,371,201"
Ovarian Cancer,2008,NCI,N1CN25512A-100-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,HENRY FORD HEALTH SYSTEM,MI,"$892,391"
Ovarian Cancer,2008,NCI,N1CN25476A-75-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial",NO PI IDENTIFIED,"WESTAT, INC.",MD,"$2,685,388"
Ovarian Cancer,2008,NCI,5P01CA078039-09,0002,Molecular Pharmacology & Biochemistry of Dual Specificity Phosphatase Inhibitors,"LAZO, JOHN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$276,044"
Ovarian Cancer,2008,NCI,5P01CA017054-30,0001,Hormone Therapy and Risk of Ovarian Cancer,"WU, ANNA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$403,783"
Ovarian Cancer,2008,NCI,4R33CA110499-02,,Molecular Profiling to Predict Response to Chemotherapy,"LANCASTER, JOHNATHAN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$322,613"
Ovarian Cancer,2008,NCI,5P50CA083638-10,0003,AKT as a Biomarker of Ovarian Cancer Progression and a Target for Therapy,"TESTA, JOSEPH",FOX CHASE CANCER CENTER,PA,"$799,787"
Ovarian Cancer,2008,NCI,5P50CA083638-10,0010,Mechanism of Cox-2 Inhibition in Ovarian Cancer Prevention,"XU, XIANGXI MIKE",FOX CHASE CANCER CENTER,PA,"$603,663"
Ovarian Cancer,2008,NCI,5P50CA083638-10,0011,Anti-Mullerian Inhibiting Substance Type II Receptor (MISIIR) Immunoconjugates to,"ADAMS, GREGORY",FOX CHASE CANCER CENTER,PA,"$733,901"
Ovarian Cancer,2008,NCI,5P01CA129186-02,0002,"HOMOLOGY- DEPENDENT DNA REPAIR, HYPOXIA, AND CANCER THERAPY","GLAZER, PETER",YALE UNIVERSITY,CT,"$302,309"
Ovarian Cancer,2008,NCI,N44CN73301-3-0-1,,Biomarker Screening with Revoluntionary Neoabs,NO PI IDENTIFIED,NEOCLONE BIOTECHNOLOGY INTERNATIONAL,WI,"$206,777"
Ovarian Cancer,2008,NCI,5U54CA113001-05,0003,Chromatin Landscaping of TGF-P/SMAD Signaling Targets,"SALTZ, JOEL",OHIO STATE UNIVERSITY,OH,"$249,546"
Ovarian Cancer,2008,NCI,5U54CA113001-05,0004,Predicting Drug Resistance in Cancer Genomes by DMA Methylation Profiling,"NEPHEW, KENNETH",INDIANA UNIVERSITY,IN,"$396,106"
Ovarian Cancer,2008,NCI,N1CN25511A-83-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,,,"$669,636"
Ovarian Cancer,2008,NIAID,5P01AI068730-02,0005,COMPLEMENT IN CANCER ESTABLISHMENT AND GROWTH,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$342,004"
Ovarian Cancer,2008,NCI,4R33CA122904-02,,Identification of T Cell-Defined Antigens in Ovarian Cancer,"YEE, CASSIAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$391,435"
Ovarian Cancer,2008,NCI,5P50CA105009-05,0001,Modifiable Risk Factors and Gene/Environment interactions in Ovarian Cancer,"HANKINSON, SUSAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$172,468"
Ovarian Cancer,2008,NCI,5P50CA105009-05,0002,Genetic Changes in Early Stage Ovarian Cancer,"MOK, SAMUEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$222,918"
Ovarian Cancer,2008,NCI,5P50CA105009-05,0003,"Identifying Novel Serum, Plasma, and Urine Biomarkers of Occult Ovarian Cancer","SKATES, STEVEN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$261,414"
Ovarian Cancer,2008,NCI,5P50CA105009-05,0004,Defining Clinical Response Genes in High-Risk Epithelial Ovarian Carcinoma,"SEIDEN, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$296,575"
Ovarian Cancer,2008,NCI,5P50CA105009-05,0005,Novel Immunotherapeutic Approaches for Ovarian Cancer,"KUFE, DONALD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$303,237"
Ovarian Cancer,2008,NCI,5P50CA105009-05,9001,Core--Biostatistics,"FINKELSTEIN, DIANNE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$355,802"
Ovarian Cancer,2008,NCI,5P50CA105009-05,9003,Developmental Research Program,"SEIDEN, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$155,254"
Ovarian Cancer,2008,NCI,5P50CA105009-05,9004,Career Development Program,"SEIDEN, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$155,255"
Ovarian Cancer,2008,NCI,7P01CA104177-04,0003,MDA-7/IL-24: Therapy of Ovarian Cancer,"CURIEL, DAVID",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,546"
Ovarian Cancer,2008,NCI,7P01CA104177-04,9001,Core--Protein Purification,"GUPTA, PANKAJ",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$112,665"
Ovarian Cancer,2008,NCI,7P01CA104177-04,9002,Core--Viral Vector,"CURIEL, DAVID",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$107,756"
Ovarian Cancer,2008,NCI,3U01CA111273-04S1,,Affinity-Based Serum Proteomics: Breast and Ovarian Can*,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$176,000"
Ovarian Cancer,2008,NCI,N1CN25404A-39-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial - Lab",NO PI IDENTIFIED,,,"$1,654,777"
Ovarian Cancer,2008,NCRR,5G12RR003032-24,5467,DISSECTING COX-1 RELATED GENE PATHWAYS IN OVARIAN CANCER,"KHABELE, DINEO",MEHARRY MEDICAL COLLEGE,TN,"$140,014"
Ovarian Cancer,2008,NCRR,5G12RR003037-24,5479,ROLES OF MSP58 IN NUCLEAR FUNCTION AND ONCOGENESIS,"ZHONG, HUALIN",HUNTER COLLEGE,NY,"$118,887"
Ovarian Cancer,2008,NCRR,5P51RR000163-49,6115,"FEMALE ANDROGEN:  METABOLIC SYNDROME, CARDIOVASCULAR DISEASE, OVARIAN CANCER","STOUFFER, RICHARD",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$54,119"
Ovarian Cancer,2008,NIA,5P51RR000163-49,6115,"FEMALE ANDROGEN:  METABOLIC SYNDROME, CARDIOVASCULAR DISEASE, OVARIAN CANCER","STOUFFER, RICHARD",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,393"
Ovarian Cancer,2008,NCRR,5P51RR000163-49,6146,BIOLOGY OF THE PRIMATE OVARIAN SURFACE EPITHELIUM,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$54,119"
Ovarian Cancer,2008,NIA,5P51RR000163-49,6146,BIOLOGY OF THE PRIMATE OVARIAN SURFACE EPITHELIUM,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,393"
Ovarian Cancer,2008,NCRR,5P51RR000163-49,6147,ESTROGEN-MEDIATED CELL CYCLE ARREST VIA P53 AND P21,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$27,009"
Ovarian Cancer,2008,NIA,5P51RR000163-49,6147,ESTROGEN-MEDIATED CELL CYCLE ARREST VIA P53 AND P21,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,$695
Ovarian Cancer,2008,NCRR,3P51RR000163-49S1,6635,SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER,"SMITH, M",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$320,000"
Ovarian Cancer,2008,NCRR,2M01RR000043-48,6788,"CLINICAL TRIAL: A PHASE II, OPEN-LABEL, NON-COMPARATIVE, INTERNATIONAL, MULTICEN","WEITZEL, JEFFREY",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$4,806"
Ovarian Cancer,2008,NCRR,2M01RR000043-48,6813,PHASE I TRIAL OF INTRAVENOUS FENRETINIDE (4-HPR) FOR PATIENTS WITH HEMATOLOGI,"MOHRBACHER, ANN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$155,024"
Ovarian Cancer,2008,NCRR,5M01RR000425-39,7339,BLOOD AND TISSUE BANKING IN GYNECOLOGICAL MALIGNANCIES,"KARLAN, BETH",LA BIOMED RES INST/ HARBOR UCLA MED CTR,CA,"$2,193"
Ovarian Cancer,2008,NCRR,5M01RR000188-44,7794,THE MOLECULAR BASIS OF FAMILIAL CANCER PREDISPOSITION SYNDROMES,"PLON, SHARON",BAYLOR COLLEGE OF MEDICINE,TX,"$1,785"
Ovarian Cancer,2008,NCRR,5M01RR000070-46,8028,CLINICAL TRIAL: OVARIAN CANCER PATIENTS WITH RECURRENT SYMPTOMATIC MALIGNANT ASC,"BERAK, JONATHAN",STANFORD UNIVERSITY,CA,"$1,138"
Ovarian Cancer,2008,NCRR,5M01RR000070-46,8029,CLINICAL TRIAL: ADVANCED EPITHELIAL OVARIAN CANCER AFTER A COMPLETE RESPONSE TO,"BERAK, JONATHAN",STANFORD UNIVERSITY,CA,$341
Ovarian Cancer,2008,NCRR,5M01RR000071-45,8308,"SURGERY, PSYCHOLOGICAL FACTORS, BLOOD CLOTTING FACTORS IN WOMEN GYN PROCEDURES","HIGGINS, SARA",MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NY,"$1,142"
Ovarian Cancer,2008,NCRR,5M01RR000096-47,8501,CANCER SCREENING AND PREVENTION PROJECT FOR HIGH RISK WOMEN,"MUGGIA, FRANCO",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$16,654"
Ovarian Cancer,2008,NCRR,5M01RR000096-47,8512,CLINICAL TRIAL: OSI 774 WITH CARBOPLATIN AND PACLITAXEL IN OVARIAN OR PERITONEAL,"BLANK, SALLY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,$948
Ovarian Cancer,2008,NCRR,5M01RR000096-47,8515,GOG-0199:  USING SALPINGO-OOPHORECTOMY AND CA-125 TO SCREEN FOR OVARIAN CANCER,"BLANK, SALLY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,$406
Ovarian Cancer,2008,NCRR,5M01RR000096-47,8569,CLINICAL TRIAL: PACLITAXEL WITH GLEEVEC IN TAXANE-PRETREATED OVARIAN CANCER,"MUGGIA, FRANCO",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,$677
Ovarian Cancer,2008,NCRR,5M01RR000096-47,8573,CLINICAL TRIAL: OXALIPLATIN PLUS TOPOTECAN FOR PATIENTS WITH PREVIOUSLY TREATED,"TIERSTEN, AMY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$2,708"
Ovarian Cancer,2008,NCRR,5M01RR000064-44,8598,OVARIAN CANCER SCREENING STUDY,"BUYS, SAUNDRA",UNIVERSITY OF UTAH,UT,"$3,525"
Ovarian Cancer,2008,NCRR,5M01RR000847-35,8675,"SYNTHETIC PEPTIDES IN ADJUVANT VACCINATION IN OVARIAN, PERITONEAL, FALLOPIAN CA","JAZAERI, AMIR",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$15,512"
Ovarian Cancer,2008,NCRR,5M01RR023942-02,5241,CANCER GENETICS NETWORK (CGN) OVARIAN SCREENING PILOT TRIAL IN HIGH RIS WOMEN,"ISAACS, CLAUDINE",GEORGETOWN UNIVERSITY,DC,"$21,403"
Ovarian Cancer,2008,NCI,5P01CA042745-22,0014,LIPOSOMES,"DEWHIRST, MARK",DUKE UNIVERSITY,NC,"$143,991"
Ovarian Cancer,2008,NCRR,5P20RR016479-08,6342,ANTI-OVARIAN CANCER PROPERTIES OF RU-486,"TELLERIA, CARLOS",UNIVERSITY OF SOUTH DAKOTA,SD,"$28,696"
Ovarian Cancer,2008,NCRR,5P20RR015578-09,6443,GONAD-SPECIFIC TRANSCRIPTION FACTORS,"FREIMAN, RICHARD",BROWN UNIVERSITY,RI,"$235,609"
Ovarian Cancer,2008,NCRR,5P20RR016477-08,6467,SIGNALING PATHWAYS IN APIGENIN-INHIBITING TUMOR GROWTH,"CHEN, ALLAN",MARSHALL UNIVERSITY,WV,"$164,796"
Ovarian Cancer,2008,NCRR,5P20RR016474-08,6647,"VITAMIN E,OVARIAN CANCER AND FERTILITY","MURDOCH, WILLIAM",UNIVERSITY OF WYOMING,WY,"$194,206"
Ovarian Cancer,2008,NCRR,5P41RR004050-20,8532,ANALYSIS OF EXOSOMES FROM CISPLATIN RESISTANT AND SENSITIVE OVARIAN CANCER,"HOWELL, STEPHEN",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$9,756"
Ovarian Cancer,2008,NCI,Y1CO8103-1-0-7,,caBIG-ICR Software Development Support for TCGA-Ovarian Cancer,NO PI IDENTIFIED,,,"$245,318"
Ovarian Cancer,2008,NCI,5P30CA006516-44,9035,Core - Rapdi Case Identification,"MUELLER, NANCY",DANA-FARBER CANCER INSTITUTE,MA,"$205,193"
Ovarian Cancer,2008,NCI,5P30CA014089-33,9001,Molecular and Cell Biology,"LANDOLPH, JOSEPH",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$381,691"
Ovarian Cancer,2008,NCI,5P30CA014089-33,9005,Transgenic/Knockout Mouse Core Facility,"MAXSON, ROBERT",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$222,143"
Ovarian Cancer,2008,NCI,5P30CA014236-34,0010,BREAST AND OVARIAN ONCOLOGY,"LYERLY, HERBERT",DUKE UNIVERSITY,NC,"$25,791"
Ovarian Cancer,2008,NCI,5P50CA083639-09,0007,Early Detection of Epithelial Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$288,852"
Ovarian Cancer,2008,NCI,5P50CA083639-09,0008,Cell-specific Targeting of Ovarian Cancer Vasculature,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$186,960"
Ovarian Cancer,2008,NCI,5P50CA083639-09,0009,Development of E1A Gene Therapy in Ovarian Cancer,"HUNG, MIEN-CHIE",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$147,397"
Ovarian Cancer,2008,NCI,5P50CA083639-09,0010,Targeting the PI3K Pathway in Ovarian Cancer,"MILLS, GORDON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$147,397"
Ovarian Cancer,2008,NCI,5P50CA083639-09,9003,Administrative Core,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$19,476"
Ovarian Cancer,2008,NCI,5P50CA083639-09,9005,Pathology Core,"BROADDUS, RUSSELL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$144,481"
Ovarian Cancer,2008,NCI,5P50CA083639-09,0011,Developmental Research Program,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$123,789"
Ovarian Cancer,2008,NCI,5P50CA083639-09,0012,Career Development Program,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$123,789"
Ovarian Cancer,2008,NCI,5P50CA083639-09,0013,Genome Based Marker and Therapy Development in Ovarian Cancer,"GRAY, JOE",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$227,260"
Ovarian Cancer,2008,NIA,1Z01AG000395-01,,Expression and roles of claudin-3 and claudin-4 in ovarian cancer,"MORIN, PATRICE",NIH,,"$653,330"
Ovarian Cancer,2008,NIA,1Z01AG000396-01,,Mechanisms of drug resistance in ovarian cancer,"MORIN, PATRICE",NIH,,"$265,415"
Ovarian Cancer,2008,NIA,1Z01AG000397-01,,Claudin-7 in ovarian cancer,"MORIN, PATRICE",NIH,,"$223,550"
Ovarian Cancer,2008,NIA,1Z01AG000398-01,,Expression and roles of microRNAs in ovarian tumorigenesis,"MORIN, PATRICE",NIH,,"$223,550"
Ovarian Cancer,2008,NCI,1Z01BC005691-17,,Inhibition of p53 Tumor Suppressor Function by HTLV-I,"BRADY, JOHN",NIH,,"$972,122"
Ovarian Cancer,2008,NCI,1Z01BC007349-16,,New Cancer Drugs: Integrative Pharmacogenomics and Pharmacoproteomics,"WEINSTEIN, JOHN",NIH,,"$336,151"
Ovarian Cancer,2008,NCI,1Z01BC008753-26,,Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies,"PASTAN, IRA",NIH,,"$1,710,990"
Ovarian Cancer,2008,NCI,1Z01BC010020-13,,Clinical Trials with Immunotoxins,"PASTAN, IRA",NIH,,"$1,026,594"
Ovarian Cancer,2008,NCI,1Z01BC010549-05,,Zebrafish Models of Cancer,"HICKSTEIN, DENNIS",NIH,,"$1,031,640"
Ovarian Cancer,2008,NCI,1Z01BC010696-04,,Study of Hereditary Renal Syndromes,"MERINO NEUMANN, MARIA",NIH,,"$336,529"
Ovarian Cancer,2008,NCI,1Z01BC010823-02,,Asparagine Synthetase as a Biomarker for L-asparaginase Rx of Ovarian Cancer,"WEINSTEIN, JOHN",NIH,,"$168,075"
Ovarian Cancer,2008,NCI,1Z01BC010891-01,,Antibody Therapy of Cancer,"HO, MITCHELL",NIH,,"$55,533"
Ovarian Cancer,2008,NCI,1Z01BC010935-01,,Regulation of Metastasis and Angiogenesis by Autotaxin and its Products,"STRACKE, MARY",NIH,,"$466,155"
Ovarian Cancer,2008,NCI,1Z01BC011054-01,,Nuclear Factor-kappaB in Ovarian Cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$513,739"
Ovarian Cancer,2008,NCI,1Z01CP010145-09,,Intervention Trials in Persons at Increased Genetic Risk of Cancer,"GREENE, MARK",NIH,,"$5,949,905"
Ovarian Cancer,2008,NCI,1Z01CP010152-09,,PLCO Trial Etiologic and Early Marker Study,"HAYES, RICHARD",NIH,,"$2,342,091"
Ovarian Cancer,2008,NCI,1Z01CP010183-06,,Descriptive Studies and Record Linkage,"ANDERSON, WILLIAM",NIH,,"$1,551,349"
Ovarian Cancer,2008,NIBIB,1Z01EB000048-02,,Development of Instrumentation for Fluorescence-Guided Surgery,"MORGAN, NICOLE",NIH,,"$28,344"
Ovarian Cancer,2008,NICHD,1Z01HD000265-11,,Laser Capture For Macromolecular Analysis Of Normal Development And Pathology,"BONNER, ROBERT",NIH,,"$213,483"
Ovarian Cancer,2008,NCI,1Z01SC000165-17,,The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis,"BIRRER, MICHAEL",NIH,,"$384,502"
Ovarian Cancer,2008,NCI,1Z01SC000181-16,,The Molecular Genetics of Gynecologic Cancers,"BIRRER, MICHAEL",NIH,,"$576,752"
Ovarian Cancer,2008,NCI,1Z01SC006353-26,,Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"BRECHBIEL, MARTIN",NIH,,"$814,632"
Ovarian Cancer,2008,NCI,1Z01SC007263-16,,TRAIL-induced Cell Death in Breast Cancer Cells,"LIPKOWITZ, STANLEY",NIH,,"$433,310"
Ovarian Cancer,2008,NCI,1Z01SC009163-21,,Signal Transduction Therapy--Basic Science,"KOHN, ELISE",NIH,,"$396,183"
Ovarian Cancer,2008,NCI,1Z01SC009374-17,,Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,"KOHN, ELISE",NIH,,"$321,898"
Ovarian Cancer,2008,NCI,1Z01SC009375-16,,Signal Transduction Therapy--Clinical,"KOHN, ELISE",NIH,,"$767,604"
